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Aim of this study was to investigate heart valve calcification process by different biomineralogical techniques to provide
morphological and chemical features of the ectopic deposit extracted from patients with severe mitral and aortic valve stenosis,
to better evaluate this pathological process. Polarized light microscopy and scanning electron microscopy analyses brought to light
the presence of nodular and massive mineralization forms characterized by different levels of calcification, as well as the presence
of submicrometric calcified globular cluster, micrometric cavities containing disorganized tissue structures, and submillimeter
pockets formed by organic fibers very similar to amyloid formations. Electronmicroprobe analyses showed variable concentrations
of Ca and P within each deposit and the highest content of Ca and P within calcified tricuspid aortic valves, while powder X-ray
diffraction analyses indicated in the nanometer range the dimension of the pathological bioapatite crystals.These findings indicated
the presence of highly heterogeneous deposits within heart valve tissues and suggested a progressive maturation process with
continuous changes in the composition of the valvular tissue, similar to themultistep formation process of bone tissue.Moreover the
micrometric cavities represent structural stages of the valve tissue that immediately precedes the formation of heavily mineralized
deposits such as bone-like nodules.
1. Introduction
Several physiological and pathological mineralized deposits
are present in the human body. The major mineralized
products (enamel, dentin, and bone) are formed by well-
controlled processes of mineralization [1, 2]. Other deposits
(e.g., dental calculus, urinary stones, arthritic cartilage, and
heart valve calcification) are produced by pathologic min-
eralization. Calcific aortic valve stenosis is a major health
problem facing our aging society and, after hypertension
and coronary artery disease, is the third most common
cardiovascular disorder and the most common indication for
surgical valve replacement in the United States [3]. Despite
the fact that ectopic deposits within heart valve tissues
are intensively investigated, their formation mechanism is
still unclear, and currently there are no effective medical
treatments to delay valve calcification course progression.
The calcified deposits are composed of mineral and
organic components and represent inorganic phases pro-
duced by the activity of living organisms, better known
as biominerals [4]. Most pathologic biomineral deposits,
generically termed calcifications or ectopic calcifications, are
composed of a mixture of calcium phosphate phases. The
formation of each phase depends on the combination of
pH, temperature, and solution composition [5–8], and the
characteristics of these deposits are different from normal
mineralized tissues and from their inorganically produced
counterparts. As the formation of biominerals is associated
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Table 1: Patients characteristics, experimental analyses performed (SEM-EDS, scanning electron microscopy with energy dispersive
spectrometry; PXRD, powder X-ray diffraction; EMP, electron microprobe analysis; PLM, polarized light microscopy), and average content
of calcium (Ca) and phosphorus (P) in different types of calcified valve. Ca and P contents are expressed as oxide-weight percent values and
as atomic Ca : P ratio. Values are mean ± SD.
Characteristic Overall
𝑁 = 36
Tricuspid aortic valve
𝑁 = 29
Bicuspid aortic valve
𝑁 = 3
Mitral valve
𝑁 = 4
Age, y 72.4 ± 10 74.5 ± 7.8 55 ± 15 69 ± 9
Males 25 (69.4%) 20 (69%) 3 (100%) 2 (50%)
SEM-EDS 20 (55.5%) 13 (45%) 3 (100%) 4 (100%)
PXRD 27 (75%) 23 (79%) 2 (66%) 2 (50%)
EMP 5 (14%) 2 (7%) 2 (66%) 1 (25%)
PLM 5 (14%) 2 (7%) 2 (66%) 1 (25%)
CaO 40 ± 5.7 44.3 ± 4.3 35.3 ± 8.2 40.7 ± 3.4
P2O5 28.1 ± 4.2 30.85 ± 3.3 25 ± 6 28.85 ± 2.3
Ca : P 1.8 ± 0.08 1.82 ± 0.05 1.8 ± 0.105 1.78 ± 0.09
with different processes involving complex physicochemical
and biological mechanisms, we sought to better comprehend
this pathological process by conducting an interdisciplinary
study focusing on the biomineralogical features of the ectopic
deposits in heart valves and to present a novel biomineralog-
ical approach that may provide important insights into the
growth mechanisms of pathological events.
2. Materials and Methods
2.1. Valve Samples. Calcified aortic valves (tricuspid type,
𝑛 = 29; bicuspid type, 𝑛 = 3) and mitral valves (𝑛 = 4)
were obtained from Caucasian patients of both sexes and
different ages (41–90 years old) (Table 1). Samples were col-
lected as resection materials from patients undergoing valve
replacement due to severe aortic valve and mitral stenosis.
All surgical interventions were performed at the Department
of Cardiac Surgery, Treviso Regional Hospital, Italy. An
institutional committee approved the study, and the patients
gave written informed consent. Calcified valves without any
sign of inflammation were included in this study. For a
mineralogical preparation of the samples, after extraction
tissues were preserved and dehydrated in absolute alcohol,
then to sterilize the biologicalmaterial, samples were exposed
to UV radiation for almost 72 hours.
2.2. Preparation of PolishedThin Sections. As the dehydration
treatment of the samples gave to the calcified valves the
consistency of a soft rock (Figure 1) the same procedure used
for rock samples was applied for the preparation of polished
thin sections (PTS) of calcified deposits. Only samples with
an extensive calcification were chosen for PTS, because the
preparation method requires a significant amount of calci-
fication to obtain good-quality PTS. The epoxy mounting
method was used to prepare PTS with 30 𝜇m thicknesses
[9, 10].
2.3. Polarized LightMicroscopy and ElectronMicroprobe Anal-
yses. PTS were studied with an Olympus BX60 microscope
with transmitted- and reflected-polarized light (PLM). Cross
Organic tissue
 Biomineralization
Figure 1: Macroscopic images of a large mineralized deposit on
a valve leaflet after the mineralogical preparation (dehydration in
absolute alcohol and exposure to UV radiation) of the sample. The
white deposit represents the biomineral formation grownwithin the
organic tissue (in yellow) of the human heart valve.
polarized light was used to test birefringence of samples. PTS
were then coated with a thin layer of graphite, sputter-coated
with an Edwards E306A High Vacuum System, and analyzed
with a Cameca SX 50 EMP equipped with four wavelength
dispersive spectrometers (WDS) and one energy dispersive
spectrometer (EDS), at a beam current of 15.0 nA and an
accelerating voltage of 15 kV. The samples were investigated
using a defocused beam, as described by Ballirano et al.
[11]. Standards used for the quantitative chemical analyses
were all synthetic, apart from the natural fluorapatite from
Durango (Mexico) used for phosphorus (P). The synthetic
standards used were barite for sulfur (S), periclase for mag-
nesium (Mg), wollastonite for calcium (Ca), magnetite for
iron (Fe), and jadeite for sodium (Na). Electron microprobe
(EMP) was used to obtain quantitative chemical analysis of
micron-sized crystallites and backscattered electron images,
very helpful to find high-resolution spatial variations in the
chemical composition of the samples. They were used in
conjunction with spot probe analyses, either EDS or WDS
methods. At least 16 to 30 points were analyzed for each
specimen.
Pathology Research International 3
2.4. Scanning Electron Microscopy. A FEI Quanta 400MK2
scanning electron microscope (SEM) was used for mor-
phological investigations. Samples were fixed on a graphite
stub with double-faced tape and investigated in high- and
low-vacuum modes. In order to monitor that no artifacts
associated with sputter coating were formed, morphological
investigations were conducted on coated and uncoated sam-
ples. Samples were coated with a thin layer of graphite, as for
the PTS, only for high-vacuummode analysis. To investigate
the internal structure of pathological mineralized deposits,
some samples were fractured to allow analysis of freshly
broken surfaces. X-ray microanalysis was carried out with
an EDS Genesis XM2, manufactured by EDAX, and several
measurements were taken for each sample. Four PTS were
investigated by SEM as well, and X-ray maps of individual
chemical elements were acquired at a beam energy of 15 kV
using the K𝛼 lines of Ca, P, Na, Mg, and S, with a collection
time of 2 hours.
2.5. Powder X-Ray Diffraction Analyses. Powder X-ray dif-
fraction (PXRD) patterns were collected on a parallel X-
ray beam Bruker AXS D8 FOCUS automated diffractometer,
equipped with the parabolically shaped Go¨bel Mirror, using
the Cu K𝛼
1
radiation (1.54051 A˚) at 40 kV and 40mA and
operating in 𝜃-2𝜃 geometry. Data were collected in the 5–
90∘ 2𝜃 range with a step size of 0.02∘ and a counting time
of 10 s at each step. Measurements were collected at room
temperature in rotating 0.5mm capillary tube. The samples
were ground in an agatemortar into a fine powder. Two sets of
diffractograms were collected: one on untreated powders and
another on powders which have undergone deproteination
treatment made to remove the organic component of the
samples from the powders which significantly reduces the
quality of the collected data. The deproteination treatment
was performed through an enzymatic attack using trypsin in
basic pH conditions.The cards from the International Center
for Diffraction Data were used for phase identification.
The crystallite size as expression of mean diameter of
the coherent-scattering domains (𝐷) was determined with
indirect measurements using diffraction peak broadening
analysis. This was estimated using the Scherrer equation𝐷 =
(𝑘𝜆)/(𝛽 cos 𝜃) assuming (i) the line width/shape dominated
only by particle-size effects, (ii) the Scherrer constant (𝐾) as
0.9, and (iii) the peak broadening as Full Width Half Maxi-
mum (FWHM).The physical broadening of different diffrac-
tion lines, between∼25∘ and∼50∘ 2𝜃, was used after computer
fit using the Gaussian line shape to determine the FWHM.
2.6. Statistical Analysis. Computations were performed with
SPSS 19 (IBM, Armonk, NY, USA). Continuous variables
are reported as mean ± standard deviation and categorical
variables as n (%). Comparative analyses could not be
performed due to the differences among groups.
3. Results
3.1. Polarized Light Microscopy Analyses. Under PLM, the
ectopic deposit within heart valve tissue appeared as nodules
of variable dimensions from 500 𝜇m to 2-3mm completely
embedded within valve tissue and made up of a mishmash
of amorphous material and mineral (Figures 2(a) and 2(c)).
Under cross polarized light (XPL) the latter had the typical
first-order gray interference color of apatite (Figures 2(b) and
2(d)). Anomalous interference colors were sometimes seen
at the sample interface, probably due to reaction between
organic material and the epoxy resin used for polished thin
section preparation.
3.2. Backscattered Electron Images and Scanning Electron
Microscopy. Backscattered electron (BSE) images on PTS,
obtained by either EMP or SEM-EDS analyses, confirmed
the presence of millimeter nodular formations completely
embedded in the heart valve tissue that instead appeared
to be not mineralized. Within the millimeter nodules we
observed areas with different brightness showing a grayscale
range indicative of differences in mean atomic number
(Figure 3(a)): a massive mineral formation with a lower
brightness and micrometric nodules with higher brightness
embedded within the massive mineral matrix. The presence
of grayscale range allowed us to infer a nonuniform chemical
composition of the mineralized tissue. Both micrometric
nodules and the massive formation had the same chemical
elemental composition, as indicated by energy dispersive
spectrometry (EDS) spectra (Figures 3(b) and 3(c)), even if
we noted a different amount of carbon (C) independently of
the carbon coating and sulphur (S) between the light grey
and the grey minerals in Figure 3(a). In particular the areas
having lower brightness (lowest mean atomic number) were
always associated with high content of C and S (Figure 4)
indicating a greater amount of organic extracellular matrix
(ECM).
Elemental mapping confirmed the presence of high
concentrations of Ca and P within the brightest zones of
Figure 3(a) and the presence of high concentration of S only
in association with the ECM surrounding the pathological
deposit. In contrast, the concentrations of Na and Mg were
very low and probably below the detection limit of the
instrument (Figure 5).
Investigations on PTS brought to light also the presence
of circular cavities (Figure 6) of variable size similar to vugs
found within rocks, filled with fragments of disorganized
and mineralized collagen (Figures 6(b) and 6(c)). Very large
pockets filled with organic fibers formed by C, Na, and S
without any trace of biomineralization, similar to amyloid-
like fibrils [12, 13], were also observed (Figure 7).
At high magnifications SEM analyses revealed the pres-
ence of coalescent spherical particles (Figure 8). The latter
were variably sized and had a diameter from fewmicrometers
up to nanometer range (Figure 8(d)).They were present in all
the types of valves studied (bicuspid aortic valve, tricuspid
aortic valve, and mitral valve), but in some samples they
presented with a different degree of agglomeration.
High-resolution images also revealed a strict relation-
ship between fine collagen fibers and spherical parti-
cles (Figure 8(b)). SEM analyses conducted on coated and
uncoated samples confirmed the same results.
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Figure 2: PLM analysis of valve nodules. Appearance of nodules of variable dimensions embedded in the valve tissue of a mineralized
bicuspid aortic valve (Tv20ab) under transmitted PLM (a, c). (b, d) Under XPL the presence of extinguished zones is indicative of amorphous
component. Zones having the typical first-order gray interference color are suggestive for apatite within the nodule. Contact between organic
tissue and the epoxy resin was characterized by the presence of anomalous colors due to reaction between the two (b).
3.3. Electron Microprobe Analyses. EMP data indicated that
the chemical variability of each sample was great; Ca and P
concentrations, as well as the atomic Ca : P ratio, changed
significantly from point to point. In addition, there was sub-
stantial chemical variability also in the different types of heart
valve studied. Calcified tricuspid aortic valves had the highest
and most uniformly distributed Ca and P concentrations
and a high Ca : P ratio; bicuspid aortic valves had the lowest
Ca and P concentrations, with less uniform distribution of
Ca and P within the calcified deposits; the mitral valve
analyzed presented Ca and P concentrations similar to those
in tricuspid aortic valves. The chemical variability of Ca and
P is given in Figure 9, whereas their average content and
the mean Ca : P ratio are given in Table 1. Moreover the
comparison between the two different types of aortic calcified
valves showed a greater content of Ca and P within the
tricuspid aortic valve than bicuspid aortic valve (Figure 10).
Despite the variable concentrations of Ca and P in each
sample, the atomic Ca : P ratio for each calcified valve was
relatively uniform (Table 1).The calculatedmeanCa : P values
fell in the so-called “AB-type carbonated apatite” range, which
corresponds to the presence of carbonate (CO
3
2−) in the
apatite lattice [14]. Thus, the chemical variability of each
sample seems to be strictly regulated by its carbonate content.
This is not detectable by EMP, but we have well documented
its presence with Raman and infrared spectroscopy published
elsewhere [15].
3.4. Powder X-Ray Diffraction Analyses. X-ray diffraction
patterns of the untreated powders showed a diffuse back-
ground due to organic component (Figure 11(a)); however
the enzymatic attack cleaned successfully the powders from
the organic matter and revealed how this is extended in
the samples (Figure 11(b)). PXRD patterns confirmed the
lattice structure to be consistent with that of standard
hydroxylapatite, although the latter is significantly more
crystalline. However the calcification appears to have a good
crystallinity degree as indicated by the resolved diffraction
peaks. All samples showed the same diffraction pattern and
broadening of the diffraction peaks indicating very small
crystallite size. According to Scherrer equation, all samples
appear to be in the nanometer range with average crystallite
domains size between 20 and 24 nm (see Supplementary
Tables 1 and 2 in Supplementary Material available online at
http://dx.doi.org/10.1155/2015/342984).
3.5. Feasibility. Several difficulties arise when studying the
mineral component of calcified tissue and its organic matrix
through purely mineralogical techniques. The main diffi-
culties are linked to (1) the application of complementary
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Figure 3: BSE image and EDS analyses of PTS (sample Tv20ab). (a) Millimeter nodule embedded in the heart valve tissue. The nodule
appears to be formed by a massive mineral formation with a low brightness in which smaller nodules with higher brightness are visible. The
EDS spectra of these zones with different brightness are given in panels (b) and (c); these show that Ca, P, and O are the main chemical
elements that made up the heart valve mineralized tissues, confirming their calcium phosphate nature. Mg, Na, and S were also detected; the
massive mineral formation characterized by a lower brightness (spot a) than micrometric nodules (spot b) had a greater content of carbon
(C) and sulphur (S) and represents a partially mineralized tissue while themicrometric nodules represent fully mineralized areas.The darkest
zones represent the organic matrix not mineralized (lowest mean atomic number), while the black zones represent voids in the embedding
material.
experimental techniques to obtain reliable and interpretable
results, (2) the very small amount of material, not allowing
application of all experimental techniques, (3) the sample
preparation procedures, and (4) the specific features of the
pathological deposit under investigation; indeed calcium
phosphate biominerals possess peculiar characteristics that
make them very difficult to be analyzed. For example, these
are soft and beam-sensitive materials and can be subjected
to phase instability and artifacts formation. Therefore an
accurate biomineralogical study such as this work is not easy.
To date application of EMP for studying standard geo-
logical materials such as inorganic crystals formed in abiotic
systems is a routine analytical procedure; thus for calcium
phosphate phases of geological environment recommended
protocols and various operating conditions are indicated
in the literature. Conversely, analytical protocols and sam-
ple preparation procedures for EMP analysis of specific
biominerals are not still well defined. Therefore we made
an accurate samples selection to evaluate the more suitable
samples for each type of experimental analysis and then
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Figure 4: BSE-SEM analyses of PTS (sample Tv20ab). (a) High magnification image of a micrometric nodule formed by two different stages
of mineralization. The lower zone of the nodule having lower brightness had greater content of C and S (spot a) (b) than the upper zone of
the nodule (spot b) (c). This indicates a partially mineralized organic matrix for the lower zone of the nodule and a fully mineralized tissue
for the upper zone.
an evaluation of the optimal analytical conditions to obtain
correct information. We used the same criterion for SEM
analyses; moreover as the preparation of organic material for
SEM investigations can introduce a variety of damage and
artifacts, we made several morphological investigations, as
described in the text, to monitor the formation of artifacts
associated with the organic component of the samples.
4. Discussion
The first detailed report of aortic valve calcification was pub-
lished by Moenckeburg in 1904, who proposed two different
mechanisms to explain this phenomenon: (1) degeneration
of the valve leaflet layers, originating near the sinuses of
Valsalva and propagating toward the tips of the cusps, and
(2) a sclerotic process of the aortic wall involving the cusps.
Since then, a growing scientific body of evidence has been
collected on the cellular and molecular mechanisms under-
lying calcification [16, 17]. Currently valve calcification is
not considered a simple, passive, degenerative deposition of
calcium phosphate complexes on the injured valve leaflet
surface. Several mechanisms potentially promoting the cusps
dystrophic calcification have been proposed, ranging from
mechanical stress, inflammation, Ca/P homeostasis, focal
energy dissipation, immune response, andmetabolic changes
to upregulation of osteogenic genotype. Progression of calci-
fication seems to be mediated primarily by valve interstitial
cells (VICs) [18, 19]. In particular, changes in VIC phenotype
seem to have an important role in the pathogenesis of valve
calcification [20, 21], as well as in the ECM maladaptations
occurring with disease [22]. The calcifying osteoblast pheno-
type is considered the final common pathway of the heart
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Figure 5: Elemental maps (sample Tv20ab). (a) BSE-SEM image of the area used to generate elemental maps. (b) Distribution of Ca. (c)
Distribution of P. (d) Distribution of S. The arrows in panels (b) and (c) indicate completely mineralized areas characterized by very high
concentrations of Ca and P. The arrows in panel (d) indicate high concentrations of S associated only with the extracellular organic matrix
surrounding the pathological deposit.
(a)
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500 𝜇m
Figure 6: BSE-SEM analysis of circular cavities (sample Tv16m). (a) Low magnification image of a PTS. The brightest areas represent fully
mineralized zones. On the left, a massive and homogeneous deposit is visible, while in the center micrometric circular cavities are visible.
(b, c) Magnified view of the small cavities indicated in panel (a); fragments of disorganized and mineralized collagen are visible within the
cavities.
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Figure 7: (a) SEM image (sample Tv12a) of a pocket filled onlywith proteins, oxidized lipids, and collagen fibers, formed by carbon (C), oxygen
(O), sodium (Na), and sulphur (S) as indicated by the spectrum EDS in panel (b); the absence of P and Ca in the spectrum demonstrates
the nonmineralized nature of the fibers. Images of the pocket under PLM (c) and XPL (d). The birefringent of the organic fibers within the
pocket is clearly visible as well as their morphology very similar to amyloid fibrils.
valve calcification process [23], and the identification of
osteoblast-specific transcripts supports the hypothesis that
degenerative aortic valve stenosis can be considered the result
of an active, multifactorial, highly regulated process similar
to skeletal bone formation, although the regulation of these
processes is fundamentally different [24].
One mechanism involved in the pathogenesis of valve
calcification seems to be based on the activation of normally
quiescentVICs in response to different environmental stimuli
and on their differentiation into osteoblastic VICs [25].
Moreover, microRNAs are small noncoding RNAs implicated
in several cardiovascular pathologies [26], including calcific
aortic stenosis, where miR-26a, miR-195, and miR-30b were
found reduced [27]; in particular, miR-30b attenuates bone
morphogenetic protein 2-induced osteoblast differentiation
by targeting Runx2, Smad1, and caspase-3 [28]. miR-30b
has been proposed as a regulator of human aortic valvular
calcification and apoptosis, regulating the osteoblastic VICs,
but the exact link with the inorganic phase remains to be
established. Recent findings demonstrated that cells from an
extracardiac origin, such as circulating hematopoietic stem
cells, may contribute to vascular and valvular calcification,
by driving the differentiation processes. The presence of
bone marrow-derived hematopoietic stem cells has been
documented in adult valves, even if the function of these
cells in valvular pathogenesis has not been defined [29].
Although much progress has been made in understanding
the cellular mechanisms involved in the calcification process
of human heart valves, it is not clear which signaling path-
ways are responsible for initiation and progression of this
complex process. Despite the different biologicalmechanisms
described in valve calcification, the inorganic phase has
been less systematically analyzed. We aimed to apply the
mineralogical point of view to heart valve calcification, to
analyze the content of Ca and P and the physicochemical
features of the biominerals included in the valve calcifica-
tions. Therefore, we report in detail the morphological and
chemical features of the calcified deposits found on valve
tissue. Chemically, these deposits are constituted by calcium
phosphate with an apatite crystal structure very similar to
hydroxylapatite.This is in agreementwith the phase indicated
in previous reports on human heart calcification [30–37].
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Figure 8: SEM analysis of pathological biomineralization morphology. (a) Agglomeration of variably sized (micrometer range) calcified
nanoparticles, indicated by the arrows (12000x, mitral valve sample). (b) Agglomeration of spherical calcified nanoparticles in a framework of
organic filaments (bicuspid aortic valve sample), formed by extracellular matrix proteins. (c) Magnified view (25000x) of individual spherical
nanoparticle along amineralized filament, indicated by the arrow (mitral valve sample). (d) Agglomeration of spherical calcified nanoparticles
in the nanometer range at 40000x; the smallest measured nanoparticle was 262.7 nm in diameter (bicuspid aortic valve sample).
Our elemental maps clearly show that the composition of
the pathological phase is restricted to Ca and P, with a high
content of CO
3
2−, very similar to the carbonate content of
normal mineralized tissues, such as bone [15].
BSE images revealed the presence of different levels of
calcification. We observed a heavily mineralized tissue, char-
acterized by nodular formations, inside a mineral-deficient
tissue in which the organic component was still dominant.
The areas around the nodule formations represented this
type of calcification. We consider these different levels of
calcification as the expression of two different stages of
the calcification process. In this sense, the mineral-deficient
tissue appears to be in an initial stage of calcification and is
indicative of an ongoing maturation process. We hypothesize
that pathological mineral formation on valve tissue is a con-
tinuous process, similar to the multistep formation process
of bone tissue [38–40]: as the organic part of the valve is
lost, the mineral component increases. The brightest zones
such as nodules were ascribed to the final bioapatite deposit,
while the mineral-deficient tissue with minor brightness was
ascribed to the initial stage of the process.
We also identified the presence of small cavities in the
calcifications. High magnification images revealed the pres-
ence of disorganized tissue and in some cases of calcified and
fragmented fibers, within these cavities. We consider these
cavities of particular interest because they clearly show in
three dimensions the degradation and abnormal remodeling
of the ECM involved in the calcification process. We suggest
that these localized zones, which are characterized by a
disorganizedmatrix, represent a stage immediately preceding
the formation of a heavily mineralized formation, such as
bone-like nodule formations [29], and after the activation and
transition of VIC phenotype.
Calcification appears to be morphologically organized in
globular clusters of spherical particles. To date, the nature and
mechanisms of nucleation and growth of spherical calcium
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Figure 9: Chemical variability of Ca and P for three different calcified valves. The concentrations of Ca and P indicated in the histograms
represent the concentrations determined in oxide-weight percent (CaO, P
2
O
5
) for fifteen punctual analyses (indicated as spot) taken within
the same calcified deposit. Histograms showed that bicuspid aortic valves (b) were characterized by a lower content of Ca and P and by greater
variations in Ca : P concentrations. In contrast, mitral (c) and tricuspid aortic valves (a) were characterized by a higher content of Ca and P
and less variation in Ca and P concentration.
phosphate particles in pathologic states are still unclear. It is
still uncertain if these spherical particles are self-replicating
life forms or if they derive from a physicochemical phe-
nomenon without any relation to living organisms. The so-
called nanobacteria (or nanobacteria-like particles, nanobes,
and calcifying nanoparticles) have been considered by mis-
take for many years the pathogenic agents involved in the
calcification processes, and this bacteriomorphic hypothesis
was very diffuse [41–50]. However, it has been documented
that the nanoparticles observed in pathological calcification
lack RNAs and metabolic activity [50] but are associated with
mineraloprotein complexes as albumin and fetuin-A [51, 52],
also called calciprotein particles (CPPs) [52]. The estimated
values obtained from powder X-ray diffraction analyses are
in agreement with values of literature reported for similar
“pathological” deposits [53] and are indicative of anisotropic
crystallites longer in the c-direction than in the a- or b-
direction, suggesting a preferential growth orientation and
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Figure 10: Comparison between two different types of calcified
aortic valve. Histograms showed that the tricuspid aortic valve
had a major content of Ca and P (expressed as mean weight %)
compared to bicuspid aortic valve. The mean value was calculated
on thirty spots taken within each valve. The vertical bars represent
the standard deviation.
elongated shapes such as rod- or needle-like. In particular
the measurements based on the peak linked to 002 reflection
that is considered the most reliable peak for quantitative
purposes, because of being well resolved and without over-
lapping with other peaks, are in agreement with the values
estimated by Rusu et al. [54] for fully formed hydroxylapatite.
We consider these spherical aggregates the morphological
manifestation of calcifying nanoparticles ofmineralo-protein
and mineralo oxidized lipids that provide structural scaffolds
for carbonate apatite crystals [55, 56] associated with a self-
assembly process between organic and inorganic components
[54]. In fact, the smallest spherical particle we measured was
about 263 nm, whereas themean size of crystallites calculated
from PXRD was about 21 nm (see Supplementary Tables).
Therefore, we propose that these biological aggregations are
tiny bioapatite nanoparticles with crystals growing with the
support of proteins as albumin, fetuin-A, and apolipoprotein
A1, even if these types of nanoparticles simply adsorb any
available protein from their surrounding environment [56].
At the same time, these spherical morphologies can be
ascribed to extracellular vesicles- (EVs-) like particles [57,
58]. Their presence in calcified human heart valve supports
the role of an active extracellular vesicular compartment in
the formation of ectopic deposits within soft tissues.
However, complementary microanalytical techniques
applied to harder minerals, such as focused ion beam, trans-
mission electron microscopy, and laser ablation [59], are
needed in order to obtain more information on these bioa-
patite nanoparticles. We plan to apply these techniques in
further studies.
To the best of our knowledge, this is the first study
to highlight the quantitative difference in Ca and P tis-
sue concentrations between tricuspid and bicuspid aortic
valves. The bicuspid aortic valve (BAV) is the most com-
mon congenital valve anomaly, with a prevalence of 2% in
the general population and a male preponderance ratio of
2 : 1 [60]. The Ca and P content of tricuspid aortic valve
(TAV) and mitral valve were similar, but the magnitude and
the distribution of Ca and P were less in bicuspid valves
(Figure 10). On the contrary, macroscopically, the congen-
ital deformity of the BAV is associated with accelerated
degeneration and heavier calcification than tricuspid, with a
histoarchitecture of a rock-like mass of poorly mobile valve
tissue. The Ca content of sinus, cusps, and arterial walls
are similar in normal mammalian native semilunar valves
[61] and the regional variation in normal semilunar valve
tissue Ca concentrations is not predictive of later dystrophic
calcification. The difference concentrations in calcified BAV
are intriguing, as these valves are more subject to dystrophic
calcification not only in the cusps, but also in the sinus
and aortic wall. Impact of the asymmetrical hydraulic stress,
inflammation, endothelial dysfunction, and neoangiogenesis
probably affects more intensively the ECM when compared
to tricuspid valves. It has been demonstrated that genetic
factors affect the different behavior of aortic aneurisms in
BAV and TAV cases [62], as in BAV there is a reduction
in endothelial nitric oxide (NO) tissue endothelium levels,
lower NO production, and increased release of MMP-2 and
-9, determining endothelial dysfunction, activation of stretch
and stress pathways, increased hypertension, increased apop-
tosis of smooth muscle cells, and weakening ECM. The
molecular, cellular, and genetic differences between BAV and
TAV affect also the Ca and P content, but further studies are
needed to validate the biomineralogical difference of both
types of aortic valve.
Understanding the features of pathological crystals is
important if we are to obtain new insight into themechanisms
involved in valve calcification. This is fundamental for the
development of therapies targeting the biomineralization
process in order to improve the durability of surgically and
transcatheter-implanted bioprosthetic valves. Invasive and
costly surgical intervention and transcatheter implantation
are today the only effective treatments of calcific valve
stenosis.
5. Limitations
We are aware of the fact that a small sample size is the major
limitation of this study. As described above this limitation
is strictly linked to the methods of sample preparation for
specific mineralogical techniques that require a very big
amount of calcification, first of all to obtain accurate exper-
imental results and to make reproducible analyses in order to
verify their reliability when specific analytical protocols are
missing. However, the large number of different and accurate
analyses performed and the magnitude of the results are
of relevance. Moreover, to our knowledge, this is the first
report using pure mineralogical techniques applied to the
study of soft bioapatite in humans. Studies comparing data
from ultrastructural analyses, inflammatory markers, and
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Figure 11: Experimental XRD patterns relative to three different types of mineralized human cardiac valves. (a) X-ray diffraction pattern
of the untreated powders. (b) X-ray powder diffraction pattern of the biomineralization after the enzymatic attack. The main characteristic
peaks match the hydroxylapatite pattern numbers 9–432 from the ICDS.The broadening of the peaks indicates a small crystal size within the
nanometer range. a = aortic valve, ab = bicuspid aortic valve, and m = mitral valve.
biomineralogical data are ongoing and will be the object of
future publications.
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